XML 78 R58.htm IDEA: XBRL DOCUMENT v3.3.0.814
Outstanding Performance Share Units Awarded (Parenthetical) (Detail) - Performance share units
9 Months Ended
Sep. 30, 2015
shares
Year of Award 2013 | Brigatinib clinical trial enrollment  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Award vesting percent dependent upon achievement of specific commercial objectives 100.00%
Year of Award 2014 | Iclusig clinical trial enrollment  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Award vesting percent dependent upon achievement of specific commercial objectives 50.00%
Year of Award 2014 | cumulative 2 year revenues from sales of Iclusig  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Award vesting percent dependent upon achievement of specific commercial objectives 50.00%
Year of Award 2015 | Iclusig clinical trial enrollment  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of units vested upon milestone achievement 315,000
Year of Award 2015 | 2015 revenues from sales of Iclusig  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of units vested upon milestone achievement 315,000
Year of Award 2015 | total relative return on common stock 2015-2017  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of units vested upon milestone achievement 101,300
Year of Award 2015 | total relative return on common stock 2015-2017 | Measurement start Year  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Total relative return on common stock, measuring year for milestone 2015
Year of Award 2015 | total relative return on common stock 2015-2017 | Measurement end Year  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Total relative return on common stock, measuring year for milestone 2017